Detailed Narrative
Q3 FY25 Financial Performance Overview
Cholamandalam Financial Holdings reported a robust Q3 FY25 with a gross direct premium of ₹2,003 crores, marking an 8% year-on-year growth, surpassing the multi-line insurers' average of 7.2%. For the nine months ended December 2024, the Gross Direct Premium Income (GDPI) reached ₹6,095 crores, growing by 10.3% against the industry's 6.8%. The company recorded a profit before tax of ₹137 crores for the quarter, contributing to a nine-month PBT of ₹486 crores, and maintained a healthy solvency ratio of 2.14x.
Motor Business Performance and Composition
The motor business, the company's principal line, saw its share in the overall premium slightly decrease to 64% as of December YTD, from 65.9% in the previous fiscal year. The company's motor market share expanded to 5.5%. Within the motor portfolio, cars now constitute 41.2%, commercial vehicles 42.9%, and two-wheelers 15.8%. Approximately 28% of the total motor premium originates from new vehicles, with Q3 growth benefiting from festive season car sales, new OEM programs, and an uptick in agency business.
Claims and Combined Ratio Analysis
The claims ratio for Q3 FY25 improved to 72.6%, a 1.9 percentage point reduction from 74.5% in the corresponding quarter, despite the impact of the Natcat event from Fengal Cyclone in Pondicherry. The combined ratio for the quarter stood at 111.7%. When adjusted for the 1/n accounting effect, the combined ratio would have been 108.9% for the quarter and 109.4% for the nine months, comparing favorably to 110.3% and 110.4% respectively in the prior periods.
Impact of 1/n Accounting Method
In Q3, the industry adopted the 1/n method of accounting for long-term non-motor business, leading to an additional Gross Direct Premium (GDP) recognition of ₹124 crores, now reflected as premium received in advance. Management clarified that while this method impacts the combined ratio, its effect on profit before tax was minor, estimated at ₹7-8 crores, primarily due to its influence on reinsurance commission rather than net earned premium. This method also impacts Expenses of Management (EoM) compliance by diminishing the denominator.
Health Loss Ratios and Corrective Actions
The health loss ratio (including Personal Accident) for Q3 FY25 deteriorated to 75.5%. Management attributed this to the growing employer-employee group health business, which typically carries higher loss ratios. To mitigate this, the company implemented price increases for some retail health products in October and plans further product revisions in January 2025, with an expectation to reduce loss ratios to approximately 72% going forward⏳.
Technology Spend and Investment Corpus
The company's technology spend for the nine months ended December 2024 increased to ₹92 crores, up from ₹70 crores in the corresponding period, which had a marginal influence on the Expenses of Management (EOM) ratio. The investment corpus grew to ₹17,640 crores as of December 2024, generating an investment income of ₹332 crores for the quarter, supporting the company's financial stability.